Skip Navigation

QJM 2009 102(6):367-368; doi:10.1093/qjmed/hcp063
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bannon, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bannon, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Elements: In this month's issue

The first 10% of the full text of this article appears below.

Cardiac troponins are considered to be highly sensitive biochemical markers of myocardial cell injury. As a result, they are useful both in terms of diagnosis and prognosis following myocardial infarction (MI). In addition, it has been known for some time that significant elevation of troponins may be observed following percutaneous coronary intervention (PCI). The meta-analysis by Testa and colleagues in this month's issue of QJM attempts to address two particular questions: what is the significance of elevated troponin levels that are associated with PCI-related MI . . . [Full Text of this Article]

Michael Bannon

Editor, QJM


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?